Published in IBI on October 10, 2025, by Benjamin Wilkin
Wilkin, B., (2025) Comparing Organoids and Patient-derived Xenograft Models for the Development of Antibody-drug Conjugates - Crown Bioscience. https://blog.crownbio.com/comparing-organoids-and-patient-derived-xenograft-models-for-the-development-of-antibody-drug-conjugates
As precision oncology continues to reshape cancer research, understanding the molecular drivers of prostate cancer has become essential for translatio…
Read more
Although many prostate tumors are detected while still localized, prostate cancer remains a major focus of oncology drug discovery because of its high…
Read more
New data from translational research groups, platform developers, and earlystage biotech teams point to a clear trend in 2026: scalable 3D assays and …
Read more
